L-Glutamine ELISA kit – High Sensitivity – Plasma, Serum, Supernatant
Ref: IS-I-1100RGlutamine (Gln) is an abundant non-essential amino acid that is involved in several physiological functions including the regulation of the immune system . However, in some disease conditions, Gln metabolism can be highly dysregulated. In cancer, Gln is highly consumed by tumor cells as to fulfill their bioenergetic and biosynthetic requirements for proliferation. Targeting Gln catabolism – mainly Glutaminase – is currently investigated as a therapeutic approach to circumvent high Gln consumption by cancer cells and maintain a sufficient level in the microenvironment for an effective anti-tumor immune response.
The IS-I-1100 Gln ELISA kit allows for the determination of L-Glutamine in plasma and serum, originating from either preclinical or clinical samples, of a volume as low as 10μL and with a sensitivity of 3µM.
Sample type | Plasma, Serum, Cell supernatant |
Capacity | 96 tests |
Sensitivity | 3µM |
Range | 21 – 3125µM |
Assay time | Sample preparation 3h, ELISA overnight |
Reactivity | Reacts with all species |
Product overview
Product name | Glutamine ELISA kit |
Description | Competitive ELISA kit for the quantitative measurement of L-Glutamine (Gln) in plasma and serum samples. For research use only |
Format | 96-well plate |
Samples | Plasma, Serum, Cell supernatant |
Minimal sample volume | 10µL |
Reactivity | Reacts with all species |
Standard range | 21 – 3125µM |
Sensitivity |
3µM |
Specificity | No significant cross-reactivity was observed with Ornithine, Arginine, Asparagine, D-Glutamine and L-Glutamic acid |
Assay time | Sample preparation 3h and ELISA overnight |
Storage | Store at 2-8°C for up to 6 months |
Datasheets | Instructions for use, Material Safety Datasheet |
For research use only – Do not use for diagnostic
Sample collection & storage | EDTA Plasma
Store samples at 2-8°C for up to 48h or -20°C for longer period (up to 6 months) |
Sample preparation | Sample preparation (3 hours) |
ELISA | L-Glutamine antiserum overnight incubation, revelation and read steps (1h) |
Detailed protocol | Download instructions for use |
Selected articles on Glutamine
- Michio Miyajima, Amino acids: key sources for immunometabolites and immunotransmitters, Int Immunol, June 2020
- Wang et al. Targeting Glutaminolysis: New Perspectives to Understand Cancer Development and Novel Strategies for Potential Target Therapies, Front Oncol., Oct 2020
- Varghese et al. The glutaminase inhibitor CB-839 (Telaglenastat) enhances the anti-melanoma activity of T cell mediated immunotherapies, Mol Cancer Ther, Dec 2020